Other presentations
Patients with von Willebrand disease (VWD) often have excessive mucocutaneous bleeding (including heavy menstrual bleeding, epistaxis, and easy bruising).[7]Castaman G, Federici AB, Rodeghiero F, et al. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica. 2003;88:94-108.
http://www.haematologica.org/cgi/reprint/88/1/94
http://www.ncbi.nlm.nih.gov/pubmed/12551832?tool=bestpractice.com
[8]Du P, Bergamasco A, Moride Y, et al. Von willebrand disease epidemiology, burden of illness and management: a systematic review. J Blood Med. 2023;14:189-208.
https://www.dovepress.com/von-willebrand-disease-epidemiology-burden-of-illness-and-management-a-peer-reviewed-fulltext-article-JBM
http://www.ncbi.nlm.nih.gov/pubmed/36891166?tool=bestpractice.com
Patients may also have excessive bleeding from minor trauma/wounds or surgery (e.g., tonsillectomy, dental extraction).[7]Castaman G, Federici AB, Rodeghiero F, et al. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica. 2003;88:94-108.
http://www.haematologica.org/cgi/reprint/88/1/94
http://www.ncbi.nlm.nih.gov/pubmed/12551832?tool=bestpractice.com
[8]Du P, Bergamasco A, Moride Y, et al. Von willebrand disease epidemiology, burden of illness and management: a systematic review. J Blood Med. 2023;14:189-208.
https://www.dovepress.com/von-willebrand-disease-epidemiology-burden-of-illness-and-management-a-peer-reviewed-fulltext-article-JBM
http://www.ncbi.nlm.nih.gov/pubmed/36891166?tool=bestpractice.com
[9]Nichols WL, Hultin MB, James AH, et al. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14:171-232.
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2516.2007.01643.x/full
http://www.ncbi.nlm.nih.gov/pubmed/18315614?tool=bestpractice.com
Patients may have haematuria or central nervous system bleeding, but these are less common.[7]Castaman G, Federici AB, Rodeghiero F, et al. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica. 2003;88:94-108.
http://www.haematologica.org/cgi/reprint/88/1/94
http://www.ncbi.nlm.nih.gov/pubmed/12551832?tool=bestpractice.com
[8]Du P, Bergamasco A, Moride Y, et al. Von willebrand disease epidemiology, burden of illness and management: a systematic review. J Blood Med. 2023;14:189-208.
https://www.dovepress.com/von-willebrand-disease-epidemiology-burden-of-illness-and-management-a-peer-reviewed-fulltext-article-JBM
http://www.ncbi.nlm.nih.gov/pubmed/36891166?tool=bestpractice.com
[9]Nichols WL, Hultin MB, James AH, et al. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14:171-232.
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2516.2007.01643.x/full
http://www.ncbi.nlm.nih.gov/pubmed/18315614?tool=bestpractice.com
[10]Labarque V, Stain AM, Blanchette V, et al. Intracranial haemorrhage in von Willebrand disease: a report on six cases. Haemophilia. 2013 Jul;19(4):602-6.
https://onlinelibrary.wiley.com/doi/10.1111/hae.12142
http://www.ncbi.nlm.nih.gov/pubmed/23556472?tool=bestpractice.com
[11]Zanon E, Pasca S, Bertomoro A, et al. Spontaneous recurrent intracranial haemorrhage in a woman with type 2B von Willebrand disease: A clinical case and a brief literature review. Haemophilia. 2019 Jul;25(4):e282-5.
http://www.ncbi.nlm.nih.gov/pubmed/30924991?tool=bestpractice.com
Bleeding symptoms are usually more severe in type 2 and type 3 VWD than type 1 VWD, and may begin at an earlier age.[7]Castaman G, Federici AB, Rodeghiero F, et al. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica. 2003;88:94-108.
http://www.haematologica.org/cgi/reprint/88/1/94
http://www.ncbi.nlm.nih.gov/pubmed/12551832?tool=bestpractice.com
[8]Du P, Bergamasco A, Moride Y, et al. Von willebrand disease epidemiology, burden of illness and management: a systematic review. J Blood Med. 2023;14:189-208.
https://www.dovepress.com/von-willebrand-disease-epidemiology-burden-of-illness-and-management-a-peer-reviewed-fulltext-article-JBM
http://www.ncbi.nlm.nih.gov/pubmed/36891166?tool=bestpractice.com
[9]Nichols WL, Hultin MB, James AH, et al. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14:171-232.
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2516.2007.01643.x/full
http://www.ncbi.nlm.nih.gov/pubmed/18315614?tool=bestpractice.com
Severity of bleeding symptoms correlates with the reduction of von Willebrand factor levels and VWF activity. In type 3 VWD, FVIII is also severely decreased and may be low enough to put the patient at risk for severe bleeding symptoms more commonly seen in haemophilia A (e.g., joint bleeding [haemarthrosis], gastrointestinal bleeding).[8]Du P, Bergamasco A, Moride Y, et al. Von willebrand disease epidemiology, burden of illness and management: a systematic review. J Blood Med. 2023;14:189-208.
https://www.dovepress.com/von-willebrand-disease-epidemiology-burden-of-illness-and-management-a-peer-reviewed-fulltext-article-JBM
http://www.ncbi.nlm.nih.gov/pubmed/36891166?tool=bestpractice.com
[9]Nichols WL, Hultin MB, James AH, et al. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14:171-232.
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2516.2007.01643.x/full
http://www.ncbi.nlm.nih.gov/pubmed/18315614?tool=bestpractice.com
[12]Tosetto A, Badiee Z, Baghaipour MR, et al. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: results from 3WINTERS-IPS, an international and collaborative cross-sectional study. J Thromb Haemost. 2020 Sep;18(9):2145-54.
https://www.jthjournal.org/article/S1538-7836(22)01637-3/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/32379400?tool=bestpractice.com
Recurrent gastrointestinal bleeding may be a significant medical problem, particularly in older patients.
Patients with type 2B VWD often have mild to moderate thrombocytopenia.[13]Federici AB, Mannucci PM, Castaman G, et al. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. Blood. 2009 Jan 15;113(3):526-34.
https://ashpublications.org/blood/article/113/3/526/25145/Clinical-and-molecular-predictors-of
http://www.ncbi.nlm.nih.gov/pubmed/18805962?tool=bestpractice.com
A diagnosis of type 2B VWD may follow an incidental finding of thrombocytopenia, particularly in pregnancy, which tends to make the platelet count fall further.[14]Pavord S, Rayment R, Madan B, et al; on behalf of the Royal College of Obstetricians and Gynaecologists. Management of inherited bleeding disorders in pregnancy. Green-top guideline No 71 (joint with UKHCDO). BJOG. 2017 Jul;124(8):e193–263.
https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/1471-0528.14592
http://www.ncbi.nlm.nih.gov/pubmed/28447403?tool=bestpractice.com